GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rize Oncology Inc (XCNQ:RIZE) » Definitions » Cash Flow for Lease Financing

Rize Oncology (XCNQ:RIZE) Cash Flow for Lease Financing : C$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Rize Oncology Cash Flow for Lease Financing?

Rize Oncology's Cash Flow for Lease Financing for the three months ended in Dec. 2024 was C$0.00 Mil. Rize Oncology's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Sep. 2024 ), Rize Oncology's Cash Flow for Lease Financing remained the same in Dec. 2024 (C$0.00 Mil).

Rize Oncology Cash Flow for Lease Financing Historical Data

The historical data trend for Rize Oncology's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rize Oncology Cash Flow for Lease Financing Chart

Rize Oncology Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
- - - - -

Rize Oncology Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Rize Oncology Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rize Oncology Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Rize Oncology's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Rize Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rize Oncology Inc (XCNQ:RIZE) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XCNQ:AGN XCNQ:MOOD XCNQ:HEAL TSX:APLI XCNQ:ENBI XCNQ:NURL XCNQ:MBIO XCNQ:MYND TSXV:MRVL TSXV:VXL VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
RZONF:USA
Address
301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3
Website
https://www.rizeoncology.com
Rize Oncology Inc is is a biopharmaceutical company. The company is focused on the development of high-efficiency precision gene editing for human therapeutics applications. The company is also engaged in oncology, particularly soft tissue sarcoma, introduced by the recent exclusive licensing of STS-201, delivering small molecules targeting soft tissue sarcoma and other cancers.
Executives
William James Garner 10% Security Holder, Director
Andre Pereira Fraga Figueiredo Director

Rize Oncology Headlines

No Headlines